Is Nanjing Shi Yao a foreign company?

Nanjing Pharmaceutical Stone Technology Co., Ltd. (hereinafter referred to as "Pharmaceutical Stone Technology") is the world's leading provider of innovative chemical products and services for drug research and development. The main business includes: design, synthesis and sales of drug molecular building blocks; Process development, pilot test, commercial production and sales of key intermediates; Technical services related to the research and development of drug molecular building blocks and process production. Medical stone technology was officially put into operation in 2008. Through years of painstaking efforts, its excellent design, synthesis and supply capabilities in the field of molecular building blocks have been widely recognized by the industry. At present, the company has built more than 30,000 kinds of drug molecular building blocks with novel structure and excellent performance for global pharmaceutical enterprises. By using and combining these molecular building blocks, new drug research and development enterprises can quickly obtain a large number of candidate compounds for screening and evaluation in the drug discovery stage, and efficiently discover the structure-activity relationship of compounds, and finally determine clinical candidates, thus greatly shortening the time and economic cost of new drug research and development. In order to meet customers' different needs for chemical synthesis at all stages of new drug research and development and provide more comprehensive and long-term stable quality service, the company continues to provide laboratory-grade molecular blocks, and at the same time develops and strengthens the commercial production capacity of drug molecular blocks and key intermediates. In 20 16, Shi Yao Science and Technology acquired Shandong Di 'ai Biotechnology Co., Ltd. as a pilot and production base, further improving the three platforms of R&D, pilot and industrialization, making drug molecular building blocks widely used in all stages of drug discovery, preclinical development and clinical development, and new drug listing, and striving to create the dual brands of "Shi Yao R&D" and "Made in Shi Yao". Since its establishment, the company has reached cooperation with more than 80% of the top 20 pharmaceutical companies in the world, and provided products and services to hundreds of small and medium-sized biopharmaceutical companies around the world. 20 12 company set up Mayfair in San Francisco bay area, and set up an office in Pennsylvania on 20 17 to ensure better and faster customer service.